Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic penetration into hepatic cyst fluid
NL-OMON20974Not yet recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2019
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ciprofloxacin, piperacillin + tazobactam, doxycycline and trimethoprim + sulfamethoxazole in Infectious Hepatic Cyst (IHC) (2 arms), sponsored by Radboud University Medical Center. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
ciprofloxacinpiperacillin + tazobactamdoxycyclinetrimethoprim + sulfamethoxazole
03
Conditions
Infectious Hepatic Cyst (IHC)
Beyond the preview
Go deeper on NL-OMON20974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20974.